What do the FDA and google have in common? They are making changes that will impact your company’s communications


By Betsy Raymond Stevenson, posted October 1, 2009

So much is happening in social media that will impact pharmaceutical PR and marketing that it is hard to know where to begin in this first post.

The FDA has called for a much-needed public hearing on social media and the internet.  The hearing is scheduled for November 12 and 13, with registration closing on October 9. The FDA will accept written and electronic comments through February 28, 2010.  This is an important opportunity for healthcare communicators to have input into new regulatory policy that will impact their ability to manage their organization’s reputation in the digital world. For valuable commentary on the opportunities and challenges posed by this hearing, read Shwen Gwee’s take on Med 2.0. Mark Senak makes excellent suggestions on what industry communicators can do to prepare effective comments, and provides a link to the announcement on the Federal Register, at his blog  Eye On FDA.

Read on …
RSHC copyright © 2009